T1	intervention 0 21	Manual lymph drainage
T2	condition 91 102	lymphoedema
T3	location 631 638	Belgium
T4	eligibility 681 761	they received unilateral surgery with axillary node dissection for breast cancer
T5	No-of-participants 807 810	160
T6	intervention-participants 834 836	79
T7	control-participants 867 869	81
T8	control 875 888	control group
T9	outcome-Measure 1424 1487	cumulative incidence of and the time to develop arm lymphoedema
T10	outcome-Measure 1672 1683	lymphoedema
T11	outcome-Measure 1728 1780	health-related quality of life using the SF-36 scale
T12	outcome-Measure 1788 1818	patient reported questionnaire
T13	No-of-participants 1872 1875	154
T14	outcome 1946 1970	incidence of lymphoedema
T15	intervention-value 2000 2002	18
T16	intervention-value 2004 2007	24%
T17	control-value 2079 2081	15
T18	control-value 2083 2086	19%
T19	outcome 2226 2259	time taken to develop lymphoedema
